| All Releases |
 |
March 17, 2009
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
 |
 |
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has received the FDA's response to its citizen petition requesting that the FDA impose a 30-month stay of approval on Abbreviated New Drug Applications ("ANDAs") referencing DORYX 100 and 75 mg delayed r... |
|
|
March 17, 2009
Warner Chilcott Announces Receipt of Paragraph IV Certification Notice |
|
|
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have received a Paragraph IV Certification Notice from Impax Laboratories, Inc. ("Impax") advising that Impax has filed an Abbrevia... |
|
|
February 27, 2009
Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 |
|
|
| |
HAMILTON, Bermuda, Feb 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter and year ended December 31, 2008. Revenue in the quarter ended December 31, 2008 totaled $242.5 million, an increase of 6.5%, over the prior year quarter. Revenue for the year ended De... |
|
|
February 10, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2008 Financial Results |
|
|
| |
HAMILTON, Bermuda, Feb 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its fourth quarter and full year 2008 financial results prior to the market opening on Friday, February 27, 2009.
In addition to issuing a press release, the Company will host a conference call... |
|
|
February 3, 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction |
|
|
| |
FAJARDO, Puerto Rico and EAST WINDSOR, N.J., Feb 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Company, Inc. (a subsidiary of Warner Chilcott, Ltd., [Nasdaq: WCRX]) announced today that it has entered into an agreement with NexMed, Inc. [Nasdaq: NEXM] to acquire the U.S. rights of NexMed's topically applied alprostadil ... |
|
|
January 30, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, Jan 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Actavis") in the District Court for the District of New Jersey for infringement ... |
|
|
January 27, 2009
Warner Chilcott Announces 2009 Financial Guidance |
|
|
| |
HAMILTON, BERMUDA, Jan 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today a view of anticipated full year 2009 results.
Total revenues for 2009 are expected to be in the range of $1,015 to $1,025 million, with the results primarily being driven by LOESTRIN 24 FE, DORYX, and TACLONEX. G... |
|
|
January 22, 2009
Warner Chilcott Announces 2009 Financial Guidance Conference Call |
|
|
| |
HAMILTON, Bermuda, Jan 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its 2009 Financial Guidance after market close on Tuesday, January 27, 2009. In addition to issuing a press release, Roger Boissonneault, President and Chief Executive Officer and Paul Herendeen... |
|
|
January 16, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, Jan 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. ("Sandoz") in the District Court for the District of New Jer... |
|
|
January 12, 2009
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation |
|
|
| |
HAMILTON, Bermuda and CORONA, Calif., Jan 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Warner Chilcott Limited (Nasdaq:
WCRX) announced today that they have entered into Settlement and License
Agreements to resolve pending patent litigation related to Warner Chilcott's
oral contraceptive... |
|
|
January 8, 2009
Warner Chilcott to Present at the 27th Annual JP Morgan Healthcare Conference |
|
|
| |
HAMILTON, Bermuda, Jan 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the 27th Annual JP Morgan Conference on Tuesday, January 13, 2009 at 3:00 p.m. PT. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Executive Officer and Pau... |
|
|
January 6, 2009
Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment |
|
|
| |
HAMILTON, Bermuda, Jan 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of er... |
|
|
January 5, 2009
Warner Chilcott to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference |
|
|
| |
HAMILTON, Bermuda, Jan 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 8, 2009 at 9:00 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Execut... |
|
|
December 23, 2008
Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent |
|
|
| |
ST. DAVID'S, Bermuda, Dec 23, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company, Inc. ("Mutual"), Mylan Pharmace... |
|
|
December 22, 2008
Warner Chilcott and Barr Announce Settlement of Femcon(R) Fe Patent Challenge |
|
|
| |
ST. DAVID'S, Bermuda, Dec 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that its subsidiary Warner Chilcott Company, Inc. and Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), have entered into a Settlement and License Agreement to resolve the pending... |
|
|
December 15, 2008
Warner Chilcott to Join the Nasdaq-100 Index(R) |
|
|
| |
ST. DAVID?S, Bermuda, Dec 15, 2008 (GlobeNewswire via COMTEX News Network) -- Warner Chilcott Limited (Nasdaq:WCRX) today announced that the Company will be added to the Nasdaq-100 Index(r) effective as of the opening of trading on Monday, December 22, 2008.
"Inclusion in this group marks another milestone for Warner Chilcott. Our shares our no... |
|
|
December 8, 2008
Warner Chilcott Announces Receipt of Paragraph IV Certification Notices |
|
|
| |
ST. DAVID'S, Bermuda, Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of the Company's subsidiaries and Hospira, Inc. ("Hospira") have received Paragraph IV Certification Notices from Mutual Pharmaceutical Company, Inc. ("Mutual") and Mylan Pharmaceuticals Inc. ("Mylan")... |
|
|
November 10, 2008
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance |
|
|
| |
ST. DAVID'S, Bermuda, Nov 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Growth of promoted products and reduced operating costs continue to drive solid earnings growth.
Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2008. Revenue in the quarter ended September 30, 2008 totaled... |
|
|
October 14, 2008
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results |
|
|
| |
ST. DAVID'S, Bermuda, Oct 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its third quarter 2008 financial results prior to the market opening on Monday, November 10, 2008.
In addition to issuing a press release, the Company will host a conference call for all ... |
|
|
September 4, 2008
Warner Chilcott to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference |
|
|
| |
ST. DAVID'S, Bermuda, Sept 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at 10:20 a.m. EDT. Presenting for Warner Chilcott will be Roger Boissonneault, President and... |
|
|
|
Investor Relations
